We are live on
!
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
+35.34%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$6.7M
(-3%)
Cap. Flow
-$47.5M
Cap. Flow
% of AUM
-22.27%
Top 10 Holdings %
Top 10 Hldgs %
8.05%
Holding
403
New
118
Increased
30
Reduced
151
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lear
LEA
|
+$1.16M |
| 2 |
Americold
COLD
|
+$1.09M |
| 3 |
Republic Services
RSG
|
+$1.07M |
| 4 |
Howmet Aerospace
HWM
|
+$1.07M |
| 5 |
Intercontinental Exchange
ICE
|
+$911K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$1.96M |
| 2 |
Helen of Troy
HELE
|
+$1.64M |
| 3 |
FTI Consulting
FCN
|
+$1.55M |
| 4 |
Spire
SR
|
+$1.54M |
| 5 |
McKesson
MCK
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 16.28% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Regeneron Pharmaceuticals
REGN
$70.9B
| $956K | 0.45% |
1,533
-922
| -38% | -$523K |
|
52
Kimberly-Clark
KMB
$37B
| $955K | 0.45% |
6,755
-1,363
| -17% | -$188K |
|
53
Fox Class A
FOXA
$24.1B
| $950K | 0.45% |
35,413
-17,689
| -33% | -$478K |
|
54
Sportsman's Warehouse
SPWH
$45.7M
| $943K | 0.44% |
+66,186
| New | +$622K |
|
|
AAWW
55
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $935K | 0.44% |
21,720
-16,300
| -43% | -$572K |
|
56
Dollar General
DG
$27.3B
| $932K | 0.44% |
4,890
-345
| -7% | -$62.4K |
|
57
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$264M
| $931K | 0.44% |
30,508
+28
| +0.1% | +$839 |
|
|
ESPR
58
DELISTED
Esperion Therapeutics
ESPR
| $920K | 0.43% |
+17,936
| New | +$750K |
|
59
Match Group
MTCH
$9.07B
| $913K | 0.43% |
8,532
-2,798
| -25% | -$234K |
|
|
60
Intercontinental Exchange
ICE
$83.6B
| $911K | 0.43% |
+9,949
| New | +$911K |
|
61
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $911K | 0.43% |
23,482
-74
| -0.3% | -$2.7K |
|
|
ATNX
62
DELISTED
Athenex, Inc. Common Stock
ATNX
| $909K | 0.43% |
3,304
-514
| -13% | -$109K |
|
63
Jack Henry & Associates
JKHY
$11B
| $907K | 0.43% |
4,929
-2,995
| -38% | -$522K |
|
|
SHYF
64
DELISTED
The Shyft Group
SHYF
| $906K | 0.42% |
53,819
-8,401
| -14% | -$127K |
|
65
Murphy USA
MUSA
$11.4B
| $901K | 0.42% |
+8,005
| New | +$877K |
|
66
Procter & Gamble
PG
$348B
| $900K | 0.42% |
7,525
-1,456
| -16% | -$170K |
|
|
BNY
67
Bank of New York Mellon
BNY
$107B
| $894K | 0.42% |
+23,126
| New | +$846K |
|
68
Addus HomeCare
ADUS
$2.16B
| $893K | 0.42% |
9,645
-1,496
| -13% | -$129K |
|
69
Calix
CALX
$2.29B
| $889K | 0.42% |
+59,646
| New | +$685K |
|
70
SiteOne Landscape Supply
SITE
$4.46B
| $886K | 0.42% |
+7,771
| New | +$722K |
|
71
Travere Therapeutics
TVTX
$5.29B
| $886K | 0.42% |
+43,408
| New | +$691K |
|
72
CVS Health
CVS
$136B
| $885K | 0.41% |
+13,628
| New | +$858K |
|
73
Alarm.com
ALRM
$2.65B
| $884K | 0.41% |
13,643
-2,119
| -13% | -$107K |
|
74
Wingstop
WING
$3.75B
| $883K | 0.41% |
+6,351
| New | +$740K |
|
|
UCTT
75
Ultra Clean Holdings
UCTT
$3.75B
| $882K | 0.41% |
38,980
-6,062
| -13% | -$115K |
|
Similar funds
SIA
PV
RCM
ALIA
TL
RI
SMFS
HF
361 Capital's Q2 2020 Portfolio in Review
As of Q2 2020, 361 Capital held 403 positions worth $213M, down 3% from $220M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
361 Capital withdrew a net $47.5M in Q2 2020, closing 104 positions and reducing 151 holdings. Its most notable exit was Chemed, an estimated $1.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, 361 Capital opened a new position in Lear worth $1.27M.
- 361 Capital's largest Q2 2020 buy was Lear: 11,650 shares worth $1.27M.
- 361 Capital added most to DaVita in Q2 2020, an estimated $427K increase.
- 361 Capital's biggest Q2 2020 reduction was Williams Companies, cutting an estimated $1.41M.
- 361 Capital fully exited Chemed in Q2 2020, selling an estimated $1.96M.
- 361 Capital's ten largest holdings make up 8.1% of its $213M portfolio in Q2 2020.
- 361 Capital opened 118 new positions and closed 104 in Q2 2020.
- 361 Capital's portfolio value fell 3% quarter-over-quarter to $213M.
Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.